Physician profile
Mitra Hashemi
NPI 1225354905
$4,749.11
in general payments reported to CMS, 2019-2025
33 companies · $861 in 2025
The $861 reported for 2025 was more than what 87% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $287 · 2021: $1,792 · 2022: $410 · 2023: $326 · 2024: $966 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,153.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,246.31 | 2021 | |
| Novo Nordisk INC | $484.64 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $429.63 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $366.89 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Exact Sciences Corporation | $278.19 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $251.92 | 2021-2025 | |
| Amgen INC. | $243.68 | 2021-2025 | Evenity, Prolia, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.87 | 2020-2024 | Jardiance, Tradjenta |
| Esperion Therapeutics, INC. | $138.64 | 2021 | |
| Abbvie INC. | $121.30 | 2021-2025 | |
| Astellas Pharma US INC | $100.94 | 2020-2024 | Veozah |
| Janssen Pharmaceuticals, INC | $97.99 | 2019-2020 | |
| Glaxosmithkline, LLC. | $79.63 | 2021-2025 | Shingrix, Arexvy |
| Biohaven Pharmaceutical Holding Company LTD. | $69.60 | 2022 | |
| Abbott Laboratories | $65.63 | 2022-2025 | Freestyle Libre 3 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $65.37 | 2020-2025 | Gardasil 9, Capvaxive, Gardasil |
| Nevro Corp. | $60.53 | 2021 | |
| Amarin Pharma, INC. | $58.39 | 2020-2021 | |
| Biogen, INC. | $53.37 | 2021-2022 | |
| Seqirus USA INC | $42.70 | 2024-2025 | Fluad, Flucelvax |
| Daiichi Sankyo INC. | $41.37 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.74 | 2022 | |
| Lundbeck LLC | $28.62 | 2025 | Rexulti |
| Sanofi Pasteur INC. | $27.34 | 2024 | |
| Hologic Sales and Service, LLC | $25.49 | 2025 | Aptima |
| Becton, Dickinson and Company | $24.98 | 2025 | Bd Max System, Bd Max Instrument |
| Boston Scientific Corporation | $23.48 | 2021 | |
| Dynavax Technologies Corporation | $20.72 | 2020 | |
| Lifescan, INC. | $18.73 | 2020 | |
| Hikma Pharmaceuticals USA | $18.27 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.62 | 2020 | |
| Currax Pharmaceuticals LLC | $14.07 | 2020 | |
| Grifols USA, LLC | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitra Hashemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.